Retinal vein occlusion: An approach to diagnosis, systemic risk factors and management

Internal Medicine Journal

Volumn 38, Issue 12, 2008, Pages 904-910

  Yau, J W Y ^a   Lee, P ^a   Wong, T Y ^a   Best, J ^a   Jenkins, A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Blood coagulation disorder; Cardiovascular disease; Retinal vein occlusion; Risk factor; Thrombophilia

Indexed keywords

BLINDNESS; BLOOD CLOTTING DISORDER; CARDIOVASCULAR RISK; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; LASER COAGULATION; LOW LEVEL LASER THERAPY; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RETINA VEIN OCCLUSION; REVIEW; RISK FACTOR; THROMBOSIS; VISUAL IMPAIRMENT;

DISEASE MANAGEMENT; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; RETINAL VEIN OCCLUSION; RISK FACTORS;

EID: 58149196547     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2008.01720.x     Document Type: Review

References (45)

1. Cugati S, Wang JJ, Rochtchina E, Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol 2006 124 : 726 32.
2. Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 1996 114 : 1243 7.
3. Wong TY, Larsen EK, Klein R, Mitchell P, Couper DJ, Klein BE et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies. Ophthalmology 2005 112 : 540 47.
4. Elman MJ, Bhatt AK, Quinlan PM, Enger C. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology 1990 97 : 1543 8.
5. Shahsuvaryan ML, Melkonyan AK. Central retinal vein occlusion risk profile: a case-control study. Eur J Ophthalmol 2003 13 : 445 52.
6. Rath EZ, Frank RN, Shin DH, Kim C. Risk factors for retinal vein occlusions. A case-control study. Ophthalmology 1992 99 : 509 14.
7. Anon. Risk factors for central retinal vein occlusion. The Eye Disease Case-Control Study Group. Arch Ophthalmol 1996 114 : 545 54.
8. Anon. Risk factors for branch retinal vein occlusion. The Eye Disease Case-Control Study Group. Am J Ophthalmol 1993 116 : 286 96.
9. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001 131 : 61 77.
10. Prisco D, Marcucci R. Retinal vein thrombosis: risk factors, pathogenesis and therapeutic approach. Pathophysiol Haemost Thromb 2002 32 : 308 11.
11. Prisco D, Marcucci R, Bertini L, Gori AM. Cardiovascular and thrombophilic risk factors for central retinal vein occlusion. Eur J Intern Med 2002 13 : 163 9.
12. Recchia FM, Brown GC. Systemic disorders associated with retinal vascular occlusion. Curr Opin Ophthalmol 2000 11 : 462 7.
13. Frucht J, Shapiro A, Merin S. Intraocular pressure in retinal vein occlusion. Br J Ophthalmol 1984 68 : 26 8.
14. Luntz MH, Schenker HI. Retinal vascular accidents in glaucoma and ocular hypertension. Surv Ophthalmol 1980 25 : 163 7.
15. Hayreh SS, Zimmerman MB, Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 1994 117 : 429 41.
16. Fong AC, Schatz H. Central retinal vein occlusion in young adults. Surv Ophthalmol 1993 37 : 393 417.
17. Marcucci R, Bertini L, Giusti B, Brunelli T, Fedi S, Cellai AP et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 2001 86 : 772 6.
18. Bertram B, Remky A, Arend O, Wolf S, Reim M. Protein C, protein S, and antithrombin III in acute ocular occlusive diseases. Ger J Ophthalmol 1995 4 : 332 5.
19. Batioglu F, Atmaca LS, Karabulut HG, Beyza Sayin D. Factor V Leiden and prothrombin gene G20210A mutations in ocular Behcet disease. Acta Ophthalmol Scand 2003 81 : 283 5.
20. Paccalin M, Manic H, Bouche G, Landron C, Mercie M, Boinot C et al. Antiphospholipid syndrome in patients with retinal venous occlusion. Thromb Res 2006 117 : 365 9.
21. Asherson RA, Merry P, Acheson JF, Harris EN, Hughes GR. Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. Ann Rheum Dis 1989 48 : 358 61.
22. Vine AK. Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion. Trans Am Ophthalmol Soc 2000 98 : 493 503.
23. Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 2005 93 : 1021 6.
24. Lahey JM, Tunc M, Kearney J, Modlinski B, Koo H, Johnson RN et al. Laboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of age. Ophthalmology 2002 109 : 126 31.
25. Larsson J, Hillarp A, Olafsdottir E, Bauer B. Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein occlusion. Acta Ophthalmol Scand 1999 77 : 634 7.
26. Cruciani F, Moramarco A, Curto T, Labate A, Recupero V, Conti L et al. MTHFR C677T mutation, factor II G20210A mutation and factor V Leiden as risks factor for youth retinal vein occlusion. Clin Ter 2003 154 : 299 303.
27. Ciardella AP, Yannuzzi LA, Freund KB, DiMichele D, Nejat M, De Rosa JT et al. Factor V Leiden, activated protein C resistance, and retinal vein occlusion. Retina 1998 18 : 308 15.
28. Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O et al. Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion. Ophthalmology 2002 109 : 1105 9.
29. Greiner K, Peetz D, Winkgen A, Prellwitz W, Pfeiffer N, Hafner G. Genetic thrombophilia in patients with retinal vascular occlusion. Int Ophthalmol 1999 23 : 155 60.
30. Greiner K, Hafner G, Dick B, Peetz D, Prellwitz W, Pfeiffer N. Retinal vascular occlusion and deficiencies in the protein C pathway. Am J Ophthalmol 1999 128 : 69 74.
31. Incorvaia C, Lamberti G, Parmeggiani F, Ferraresi P, Calzolari E, Bernardi F et al. Idiopathic central retinal vein occlusion in a thrombophilic patient with the heterozygous 20210 G/A prothrombin genotype. Am J Ophthalmol 1999 128 : 247 8.
32. Palmowski-Wolfe AM, Denninger E, Geisel J, Pindur G, Ruprecht KW. Antiphospholipid antibodies in ocular arterial and venous occlusive disease. Ophthalmologica 2007 221 : 41 6.
33. Ring CP, Pearson TC, Sanders MD, Wetherley-Mein G. Viscosity and retinal vein thrombosis. Br J Ophthalmol 1976 60 : 397 410.
34. Finkelstein D. Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion. Arch Ophthalmol 1992 110 : 1427 34.
35. Anon. Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol 1997 115 : 486 91.
36. Cugati S, Wang JJ, Knudtson MD, Rochtchina E, Klein R, Klein BE et al. Retinal vein occlusion and vascular mortality: pooled data analysis of 2 population-based cohorts. Ophthalmology 2007 114 : 520 24.
37. Tsaloumas MD, Kirwan J, Vinall H, O'Leary MB, Prior P, Kritzinger EE et al. Nine year follow-up study of morbidity and mortality in retinal vein occlusion. Eye 2000 14 : 821 7.
38. Christoffersen N, Gade E, Knudsen L, Juel K, Larsen M. Mortality in patients with branch retinal vein occlusion. Ophthalmology 2007 114 : 1186 9.
39. The Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N report. Ophthalmology 1995 102 : 1434 44.
40. Mohamed Q, McIntosh RL, Saw SM, Wong TY. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2007 114 : 507 19, 24.
41. McIntosh RL, Mohamed Q, Saw SM, Wong TY. Interventions for branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 2007 114 : 835 54.
42. Leonard BC, Coupland SG, Kertes PJ, Bate R. Long-term follow-up of a modified technique for laser-induced chorioretinal venous anastomosis in nonischemic central retinal vein occlusion. Ophthalmology 2003 110 : 948 54 discussion 55.
43. Anon. Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group. Am J Ophthalmol 1984 98 : 271 82.
44. Anon. Argon laser scatter photocoagulation for prevention of neovascularization and vitreous hemorrhage in branch vein occlusion. A randomized clinical trial. The Branch Vein Occlusion Study Group. Arch Ophthalmol 1986 104 : 34 41.
45. Rabena MD, Pieramici DJ, Castellarin AA, Nasir MA, Avery RL. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007 27 : 419 25.